BioSphere Medical, Inc. To Announce Third-quarter Results on October 24, 2000; Company to Broadcast Conference Call Over the Internet at www.biospheremed.com.Business Editors ROCKLAND, Mass.--(BUSINESS WIRE)--Oct. 11, 2000 BioSphere biosphere, irregularly shaped envelope of the earth's air, water, and land encompassing the heights and depths at which living things exist. The biosphere is a closed and self-regulating system (see ecology), sustained by grand-scale cycles of energy and of Medical, Inc. (Nasdaq:BSMD), a medical device company that is pioneering the use of bioengineered microspheres to treat hypervascularized tumors and vascular malformations by occluding their blood supply, will announce financial results for the third quarter of 2000 before the open of the market on Tuesday, October 24, 2000. The company will conduct its quarterly conference call at 11:00 a.m. (ET) on Tuesday, October 24th. The call will be broadcast live over the Internet. Investors who want to hear the call should log on to www.biospheremed.com at least 15 minutes prior to the event's broadcast. About BioSphere Medical BioSphere Medical, Inc., based in Rockland, Massachusetts Rockland is a town in Plymouth County, Massachusetts, United States. The population was 17,670 at the 2000 census. with 10,199 total registered voters as of December 31, 2005. , is a medical device company focused on embolotherapy, the treatment of tumors and vascular malformations by occluding their blood supply. The company is pioneering the use of patented and proprietary bioengineered microspheres as a new class of embolics. The company's lead product, Embosphere(R) Microspheres, was cleared by the FDA FDA abbr. Food and Drug Administration FDA, n.pr See Food and Drug Administration. FDA, n.pr the abbreviation for the Food and Drug Administration. in April 2000 for marketing for the treatment of hypervascularized tumors and vascular malformations. The company is currently conducting clinical trials of Embosphere(R) Microspheres for uterine artery embolization Uterine artery embolization (UAE) or Uterine Fibroid Embolization (UFE) is a procedure where an interventional radiologist uses a catheter to deliver small particles that block the blood supply to the fibroids. See also
1. the process or condition of becoming an embolus. 2. therapeutic introduction of a substance into a vessel in order to occlude it. procedures, including uterine artery embolization. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion